通过增强FHL1稳定,USP13通过扩散大B细胞淋巴瘤中介于对伊布鲁替尼的耐药性
Yun Tao1,2, Haibing Yin1, Rong Shen1
1Department of Pathology, Affiliated Tumor Hospital of Nantong University No. 30, Tongyang North Road, Nantong 226361, Jiangsu, China.
American journal of cancer research
|August 15, 2025
概括
了解在扩散性大B细胞淋巴瘤 (DLBCL) 中的易布鲁替尼抗性至关重要. 这项研究将USP13确定为耐药性的关键因素,建议它作为改善治疗结果的潜在治疗标.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 生物化学 生物化学
背景情况:
- 扩散性大B细胞淋巴瘤 (DLBCL) 是一种流行的淋巴细胞恶性瘤.
- 布鲁顿氨酸激酶 (BTK) 抑制剂易布鲁替尼 (ibrutinib) 有益于ABC亚型DLBCL,但面临耐药性.
- 易布鲁替尼抗药性机制需要进一步阐明.
研究的目的:
- 调查翻译后修改在调解DLBCL中的易布鲁替尼抗性的作用.
- 为了确定克服易布鲁丁尼布耐药性的潜在治疗点.
主要方法:
- 在易布鲁丁尼布敏感和耐药DLBCL细胞系中对USP13表达的比较分析.
- 在体外研究涉及USP13过度表达和淘汰.
- 研究USP13与FHL1和下游信号通路 (ERK1/2,Bax,Bcl-xL) 的相互作用.
- DLBCL瘤组织的免疫组织化学染色.
主要成果:
- USP13表达在抗易布鲁丁尼布的DLBCL细胞中升高,并在易布鲁丁尼布暴露时增加.
- 过度表达USP13可促进细胞生长,降低易布鲁替尼的敏感性.
- USP13 Knockdown 增强了易布鲁替尼诱导的亡和敏感性.
- USP13对FHL1进行二氧化和稳定,导致改变ERK1/2的酸化和与亡相关的蛋白质 (Bax,Bcl-xL) 的调节.
- 高USP13表达与DLBCL患者的预后不佳相关.
结论:
- 在DLBCL中,USP13在调解易布鲁替尼抗药性方面发挥着关键作用.
- USP13与FHL1相互作用,调节亡信号通路.
- USP13代表了一个潜在的治疗标和预后生物标志物,用于DLBCL患者耐药Ibrutinib.
相关概念视频
The Intrinsic Apoptotic Pathway
6.9K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.9K
Intracellular Signaling Affects Focal Adhesions
2.8K
Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
Some...
2.8K
Abnormal Proliferation
4.6K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
NF-κB-dependent Signaling Pathway
7.8K
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
NF-κB-dependent Signaling Mechanism
The...
7.8K
B Cell Activation and Differentiation
5.6K
The adaptive immune response, a sophisticated defense mechanism, relies on the activation and differentiation of B lymphocytes, or B cells. These processes enable our bodies to mount a tailored response against specific pathogens such as bacteria, free virus particles, toxins, and parasites.
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
5.6K
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal
2.3K
Erythropoietin-producing hepatocellular carcinoma receptor (Eph) and its ligand, Eph receptor-interacting protein (Ephrin) were first discovered in the human carcinoma cell line, hence the name. Ephrin-Eph interaction guides cells to reach their appropriate location in adult tissues. They also play an essential role in the immune system by helping in immune cell migration, adhesion, and activation. Based on their structure and function, Eph is divided into two classes — EphA and EphB.
2.3K


